Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Uruguayan Sugarleaf, likely referring to *Psidium guajava* L. (guava leaf), contains key bioactive compounds such as catechin, quercetin, and guavinoside C. These compounds primarily work by inhibiting carbohydrate-digesting enzymes like α-amylase and α-glucosidase, which helps manage post-prandial blood sugar levels.
Reported Benefits (Provisional)
Origin & History
Uruguayan Sugarleaf (Erythrina speciosa) is a flowering tree species native to the subtropical regions of Uruguay. It thrives in well-drained, fertile soils with a warm climate and moderate rainfall. This botanical is traditionally valued for its sweet, mild flavor and its applications in folk medicine.
Research Narrative (Provisional)
Preliminary research, often found in ethnobotanical and phytochemical studies, suggests Uruguayan Sugarleaf's potential for antioxidant, anti-inflammatory, and digestive support. Further targeted studies are needed to substantiate its specific claims for immune and skin health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Flavonoids: Potent antioxidants supporting cellular health and anti-inflammatory responses. - Vitamin A, C: Essential vitamins for immune function and skin vitality. - Calcium, Magnesium, Potassium: Key minerals supporting various physiological functions. - Bioactive Compounds: Contribute to digestive, immune, and skin health benefits.
Reported Mechanism (Provisional)
Key compounds in Uruguayan Sugarleaf (guava leaf), including catechin, quercetin, and guavinoside C, exert their effects by inhibiting carbohydrate-digesting enzymes such as α-amylase and α-glucosidase, thereby reducing post-prandial glucose absorption. Additionally, these compounds inhibit dipeptidyl peptidase-4 (DPP4), which extends the half-life of incretins to promote insulin secretion. Further actions include inhibition of protein tyrosine phosphatase 1B (PTP1B) and 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1), contributing to improved insulin sensitivity and reduced liver glucose production.
Clinical Narrative (Provisional)
Preliminary *in vitro* and *ex vivo* studies have identified various bioactive compounds in Uruguayan Sugarleaf (guava leaf) extracts responsible for potent enzyme inhibition, notably α-amylase and α-glucosidase, indicating a potential role in blood sugar management. While these studies provide strong mechanistic insights, human clinical trials specifically investigating Uruguayan Sugarleaf or high-quality guava leaf extracts for diabetes or metabolic health are limited regarding standardized dosing and long-term efficacy. Further targeted research, including randomized controlled trials in human populations, is needed to substantiate these effects and establish clear therapeutic guidelines.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.